Issues
Volume 196 Issue 10
Editor's choice
Testosterone up. A case of disease mongering?
In this issue, Handelsman (doi: 10.5694/mja11.11277) describes changes in the patterns of testosterone prescribing in Australia from 1992 to 2010. He reports that there has been at least a twofold increase in total expenditure on prescriptions, taking into account inflation and population growth, and the increase in expenditure is greater than the increase in prescribing. Yet, ...
Annette Katelaris MB BS, MPH, FRACGP
Editorials
Disciplinary notations on the Australian Register of Medical Practitioners
Clear guidance is needed on what information should be publicly available, and for how long. One of the fundamental realignments that has occurred to the doctor–patient relationship is the capacity of patients to acquire information from the internet and, on the basis of it, interact with their practitioners in new and different ways. Some of the ...
Ian R Freckelton BA(Hons), LLB, PhD
Is the end of chronic hepatitis C virus infection in sight?
Direct antiviral agents may hold the key to eradication, but only if they reach those who will benefitIn this issue of the Journal, Dore outlines the astonishing recent progress in the treatment of hepatitis C virus (HCV) infection,1 largely triggered by the approval in 2011 by regulatory bodies, both overseas and in Australia, of the first ...
Geoffrey W McCaughan MB BS, PhD, FRACP
In brief
From the NHMRC
The full content of this article is available by downloading the PDF.
News
The full content of this article is available by downloading the PDF.
Perspectives
Not window dressing, but key to making medical research matter
Rachel Nowak explains why improving communication standards will be essential in the drive to speed research translationPssst ... Want your research findings or health guidelines to change how doctors treat patients? Then take a tip from an ex-journo: Use plain English. Keep it short. Tell stories. Journalists have, for centuries, used these tools first to hook ...
Rachel E Nowak BSc, MA, PhD
Disease mongering and low testosterone in men: the tale of two regulatory failures
Disease-awareness campaigns on low testosterone and ageing highlight the need for changes to regulations. Currently, direct-to-consumer advertising of prescription-only medicines is legal in only two industrialised countries, the United States and New Zealand. However, in countries where direct-to-consumer advertising is not allowed, including Australia, Canada and countries in the European Union, pharmaceutical companies have found ways ...
Agnes I Vitry PharmD, PhD · Barbara Mintzes PhD
Tempering hope with realism: induced pluripotent stem cells in regenerative medicine
The moral panic surrounding human embryo research has fuelled unrealistic public expectations for the imminent success of induced pluripotent stem cell therapyTraditionally, treatment for chronic degenerative conditions revolved around reducing symptoms and improving physiological functioning in the hope of gaining some (often limited) increase in life expectancy. However, in the past decade, the advent of ...
Ronald K F Fung BSc(Adv) · Ian H Kerridge MPhil, FRACP, FRCPA · Loane L C Skene LLB(Hons), LLM, LLD · Megan J Munsie BAppSc, MRepSc, PhD
Letters
Inappropriate defibrillator shocks caused by oversensing of T-wave in hyperkalaemia
To the Editor: A 62-year-old woman was admitted on 10 January 2012 for cardiac monitoring after her implantable cardioverter–defibrillator (ICD) discharged four times over a few hours. She had a history of ventricular tachycardia due to ischaemic cardiomyopathy, and had had an ICD (D284DRG Maximo II DR, Medtronic, Minneapolis, Minn, USA) inserted 6 years earlier. Her ICD had ...
Bo Xu · Howard Connor · Robert Ziffer
Targeted primary care-based mental health services for young Australians
To the Editor: The report by Scott and colleagues on the “demographic characteristics, diagnostic category, stage of illness, as well as psychosocial and vocational impairment” of 1260 patients presenting to two Sydney headspace centres1 is problematic for several reasons. No convincing data were presented to support the authors’ conclusion that the research demonstrated that “well designed youth ...
Jon N Jureidini
Targeted primary care-based mental health services for young Australians
To the Editor: The study of headspace attendees by Scott and colleagues1 illustrates problems common in articles being used for lobbying purposes in the Australian mental health policy arena. These include misrepresentation of evidence, inappropriate medicalisation, and undeclared competing interests. The authors refer to un(der)employment, lack of engagement in study, and receipt of income support as ...
Melissa Raven
Targeted primary care-based mental health services for young Australians
In reply: The detailed demographic, diagnostic and disability data we presented1 responds directly to the critics of headspace clinics. Following the initial establishment phase,1 our two centres now provide services to 390 and 411 young people per month, respectively (data from July to September 2011). Each of the 30 established headspace services now assesses an average of 265 clients ...
Ian B Hickie · Daniel F Hermens · Elizabeth M Scott
The MJA and Gawler: a case of self-censorship?
To the Editor: An important and controversial article authored by Haines and Lowenthal1 was recently published in the Internal Medicine Journal. The authors challenged evidence used by Ian Gawler on his website (iangawler.com) and in his book2 to support meditation and dietary interventions as cancer therapy. Publication of the article was subsequent to initial submission ...
Emma S McBryde
The MJA and Gawler: a case of self-censorship?
In reply: The article referred to by McBryde was submitted to the MJA in 2011. Patient consent was requested, following standard MJA practice for all manuscripts containing potentially identifying patient data or images, but this was not provided by the authors. We agree that all the information was already publicly available, and it was for ...
Annette G Katelaris
Clinical focus
The changing therapeutic landscape for hepatitis C
The next decade will be a crucial period in the public health response to hepatitis C virus (HCV) infection. The rapid development of direct-acting antiviral therapy for HCV infection has brought considerable optimism to the HCV sector, with the realistic hope that therapeutic intervention will soon be more effective and offer shorter treatment duration. ...
Gregory J Dore MPH, PhD, FRACP
Research
Hepatitis C treatment outcomes in Australian clinics
Objective: To determine hepatitis C (HCV) treatment effectiveness and predictors of response in the “real-world” Australian clinic setting. Design, setting and participants: Patients with chronic HCV, who were HCV-treatment-naive at enrolment, and were then treated with standard therapy (pegylated interferon-α plus ribavirin), were recruited prospectively through a national network of 24 HCV clinics ...
Heather F Gidding MAppEpid, PhD · Matthew G Law PhD · Janaki Amin PhD · George Ostapowicz BMed, MD, FRACP · Martin Weltman PhD, FAChAM, FRACP · Graeme A Macdonald MB BS, PhD, FRACP · Joe J Sasadeusz MB BS, PhD, FRACP · Paul AW Haber MD, FRACP, FAChAM · Jacob George MB BS, PhD, FRACP · Gregory J Dore MPH, PhD, FRACP
Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
Objectives: To develop a mathematical model to project the potential impact of hepatitis C virus (HCV) treatment on HCV infection prevalence among people who inject drugs (PWID). Design and setting: An existing model of HCV transmission among PWID was parameterised using data from Victoria, Australia, including specific parameter estimates of the number ...
Margaret E Hellard PhD, FRACP, FAFPHM · Rebecca Jenkinson BEng(Geol), MEpid, PhD · Peter Higgs BSW, MA, PhD · Mark A Stoové BaAppSci(Hons), GradDip(Ed), PhD · Rachel Sacks-Davis BA BSc(Hons[Arts]) · Judy Gold BBiomedSci(Hons), PhD · Matthew Hickman MSc, PhD, FFPH · Peter Vickerman DPhil, BSc · Natasha K Martin PhD
Pharmacoepidemiology of testosterone prescribing in Australia, 1992–2010
Objective: To describe patterns of testosterone prescribing in Australia over the past two decades by state or territory and by product type.Design and setting: Observational analysis of testosterone prescribing data obtained from two independent data sources — the Pharmaceutical Benefits Scheme (PBS) and IMS, a source of commercial pharmaceutical sales data.Main ...
David J Handelsman MB BS, FRACP, PhD
Shared care for chronic eye diseases: perspectives of ophthalmologists, optometrists and patients
Objective: To report the perspectives of optometrists, ophthalmologists and patients on a model of shared care for patients with chronic eye diseases. Design, setting and participants: Qualitative study of a model of shared care between optometrists and ophthalmologists for patients with stable age-related macular degeneration, diabetic retinopathy and glaucoma, trialled by the ...
Patricia M O’Connor PhD · C Alex Harper MB BS, FRANZCO · Cathy L Brunton BNurs · Sandra J Clews RN · Sharon A Haymes BScOptom, PhD, MPH · Jill E Keeffe OAM, PhD
Case reports
Two cases of asymptomatic HBV “vaccine breakthrough” infection detected in blood donors screened for HBV DNA
A full course of HBV vaccine results in protective levels of neutralising antibody to HBV (anti-HBs, ≥ 10 IU/L) in over 90% of adults.1 Rare cases of “vaccine breakthrough” infection in actively vaccinated individuals, mainly involving “vaccine escape mutants”, have been documented.2-4 The infecting strain usually carries mutations in the major antigenic region of HBsAg that result ...
Clive R Seed BSc, PhD · Ngaire T Jones MB BS, MMSc · Anne M Pickworth MB BS · Wendy R Graham MB BS
Medical education
Medical schools as agents of change: socially accountable medical education
Medical education reform can make an important contribution to the future health care of populations. Social accountability in medical education was defined by the World Health Organization in 1995, and an international movement for change is gathering momentum. Priority community needs are generally not well reflected in existing medical curricula. Medical schools have often ...
Richard B Murray MB BS, MPHTM, FACRRM · Sarah Larkins MB BS, MPHTM, PhD · Heather Russell BMedSci(Hons), MB BS · Shaun Ewen BAppSc(Physio), MMIL, DEd · David Prideaux BA(Hons), MEd, PhD
Reflections
Ward 5E Bed 12
Fiona hated the hospital, especially at night. The noises it made then were particularly unbearable: trolleys being wheeled down never-ending corridors, the hurried click of heels across a slick and tiled floor. On the wards, sleepless patients listened to the hushed laughter of the nurses and watched flashlights dance like fireflies behind ghostly blue curtains.
Melanie S Cheng MB BS(Hons), FRACGP
Careers
It's an emergency!
Emergency physicians are acute generalists who see patients at their most vulnerable
Sophie McNamara
Dr Phillip Webster
Dr Phillip Webster, first-year advanced trainee in emergency medicine, Gosford Hospital, and deputy chair of the Australasian College for Emergency Medicine trainee committee.
Dr Phillip
Dr Sally McCarthy reflects on her career in emergency medicine
Dr Sally McCarthy is president of the Australasian College for Emergency Medicine and a senior staff specialist in the emergency department at Prince of Wales Hospital in Randwick, Sydney. A graduate of the University of Sydney medical school, Dr McCarthy is also medical director of the Emergency Care Institute New South Wales.
Sophie McNamara
A life in the theatre
Urologist Professor Mohamed Khadra wields both scalpel and pen with precision.
Amanda Bryan
Correction
Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria
Correction Potentially misleading statement and incorrect data: In “Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria”, published online first on 14 May and in the 21 May issue of the Journal (Med J Aust 2012; 196: 582-586), there was a potentially misleading statement. Under the heading “Mortality (all-cause)” (page 584), the second sentence should read: “The median survival for patients who died during the follow-up period after splenectomy was 3.1 years (interquartile range [IQR], 1.3–5.3).” In the same article, there was also an error in the Abstract (page 582). Under “Results”, the fourth sentence should read: “The risk of severe infection was highest among patients aged > 50 years (10.1 per 100 person-years; 95% CI, 9.3–11.1) and those splenectomised for malignancy (14.2 per 100 person-years; 95% CI, 11.8–17.1).” o
David F M Looke FRACP, FRCPA, MMedSci · Naomi J Runnegar MB BS, FRACP, FRCPA
The need for data beyond primary diagnosis
Annette Katelaris MB BS, MPH, FRACGP
Gentamicin and ototoxicity: why this drug is still in use
John D Turnidge FRACP, FRCPA, FASM · John A Waterston MB BS, MD, FRACP
Are trans fats a problem in Australia?
Gunveen Kaur PhD · David Cameron-Smith PhD · Andrew J Sinclair PhD
Promoting youth mental health
Tania Janusic
Internet pornography and adolescent health
Rebecca J Guy BSc, MAppEpid, PhD · George C Patton MB BS, MD, FRANZCP · John M Kaldor BA, MA, PhD
Does football cause brain damage?
Andrew H Kaye MB BS, MD, FRACS · Paul McCrory PhD, FRACP, FACSP
Evolving psychiatric diagnosis and the DSM: hasten slowly
Paul B Fitzgerald MB BS, PhD, FRANZCP